Dynamic Changes of Immune Cells and their Relationship with Prognosis in Late-Stage Gastric Cancer Patients During PD-1 Inhibitor Immunotherapy
Dynamic Changes of Immune Cells and their Relationship with Prognosis in Late-Stage Gastric Cancer Patients During PD-1 Inhibitor Immunotherapy
Chunqin Tian1, Lichun Cui1 and Xiaoyan Wang2*
Fig. 1.
Changes in proportion of immune cells at TB (before treatment), TM (during treatment) and TA (after treatment). A, T cells; B, helper T (Th), cytotoxic T (Tc), and natural killer (NK) cells; (*) and (#), a great difference with P<0.05 to levels at TB and TM, respectively.
Fig. 2.
Changes in programmed death ligand-1 (PD-L1), CD8, and CD4expression at TB, TM, and TA. A, PD-L1; B, CD8; C, CD4; (*), a remarkable difference with P<0.05 to the level at TB.
November 2024
Pakistan J. Zool., Vol. 56
